Physician profile
Brian S Shaffer
NPI 1306986930
$5,700.40
in general payments reported to CMS, 2019-2025
53 companies · $1,319 in 2025
The $1,319 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,702 · 2020: $435 · 2021: $329 · 2022: $576 · 2023: $401 · 2024: $939 · 2025: $1,319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,659.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,658.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $625.09 | 2019-2025 | Botox |
| Astellas Pharma US INC | $624.53 | 2019-2025 | Xtandi, Myrbetriq |
| Pfizer INC. | $283.63 | 2019-2021 | |
| Janssen Biotech, INC. | $265.96 | 2019-2025 | Erleada |
| Dendreon Pharmaceuticals LLC | $251.94 | 2019-2025 | Provenge |
| Astrazeneca Pharmaceuticals LP | $247.12 | 2022-2025 | Farxiga, Lynparza |
| Sumitomo Pharma America, INC. | $240.98 | 2023-2025 | Gemtesa, Orgovyx |
| Tolmar, INC. | $225.99 | 2024-2025 | Eligard, Jatenzo, Rubraca |
| Neotract INC. | $191.15 | 2019-2020 | |
| Boston Scientific Corporation | $180.70 | 2019-2025 | Rezum Generator |
| Teleflex LLC | $172.84 | 2021-2025 | Deknatel |
| Antares Pharma, INC. | $152.67 | 2019 | |
| Coloplast Corp | $143.58 | 2019-2025 | Self-Cath |
| Calyxo, INC. | $132.85 | 2024 | Cvac Aspiration System |
| Travere Therapeutics, INC. | $122.80 | 2020-2022 |
Show all 53 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Shaffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.